MARS – evidence and controversies
The use of Molecular Adsorbent Recirculation system(MARS)for patients with liver failure was first described by Stange and Mitzner at Rostock，Germany in 1993. Within a decade”s time，MARS has become one of the most commonly used non-biological artificial liver support system. Albumin bound putative toxins of liver failure transverses across a highly specialised membrane into a recirculating albumin dialysate in which the toxins were removed by two adsorbent columns within the circuit.
肝功衰竭 肝病治疗 肝脏替代 人工肝技术
Alexander Chiu
Adult Intensive Care Unit, Queen Mary Hospital
国内会议
重庆
英文
2007-03-10（万方平台首次上网日期，不代表论文的发表时间）